ARCHIVES

Group Chairmen Propose Adding Four Trials For High Priority Status

This article is from The Cancer Letter archive.

Vol. 16 No. 27 | July 6, 1990

Download PDF Visit The Full Archive

Related Articles

Broder Issues Clinical Alert on 5-FU Levamisle Survival Advantage for Dukes C Colon Cancer

October 6, 1989

AZT Trial Unblended, Controls Get Drugs; Gallo, Essex Win Lasker With Montagnier

September 26, 1986

In Brief: Wells Tapped For GM Cancer Foundation; Calder Named NABCO Associate Director

January 17, 1997

NIEHS, Five Grantees Form Toxicogenomics Group.

November 16, 2001

Five Center Core Grants Renewed

February 2, 1979

Committee Approves Concepts For Studies In Special Populations

December 11, 1987